Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
about
Coagulation Factor XIIIA Subunit Missense Mutations Affect Structure and Function at the Various Steps of Factor XIII ActionIdentification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII DeficiencyNonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animalsEffects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility TestsCharacterization of a novel large deletion caused by double-stranded breaks in 6-bp microhomologous sequences of intron 11 and 12 of the F13A1 gene.Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy.Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants.Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.Factor XIII deficiency diagnosis: Challenges and tools.Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2.Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies.Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.[Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
P2860
Q28114772-03B4943B-9A86-46D4-932E-07EF3EC55257Q33421552-7D61C3E2-1791-4736-836A-3E504950F576Q33613405-6D085102-A64D-42CC-9787-B59B693677E5Q36719655-C8B35501-4DBA-4FF5-B6F3-40EC2075FE4DQ37242219-5C49BCE4-601D-400E-BC77-6938476A665FQ38562231-8B533414-53A3-4DB6-8ECA-F5C3E3928EDEQ38838336-57B4EB76-9598-4624-88FC-B64C338FEC08Q41672333-A9121D9C-F68D-4963-855B-E6A01EEF2BB0Q41866117-3DD61E7C-E8AD-4A1F-93D9-5FD6B2FC44C0Q45869518-47FCBABC-27A5-45E7-9C52-3D590CC31019Q45873102-11239272-68F6-45DD-8EB7-1B30FED16422Q45873332-E74B4D87-C832-469C-8FCF-C84624166BA5Q45875484-25F91D43-CD64-4FA5-A924-CDD2F3692239Q47698980-D48C1D59-6CC3-47F6-B18C-B4C8F3B65F41Q51016864-97C769D2-3E6A-42DD-B087-0082C64707E7
P2860
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Coagulation factor XIII defici ...... inherited and acquired forms.
@en
type
label
Coagulation factor XIII defici ...... inherited and acquired forms.
@en
prefLabel
Coagulation factor XIII defici ...... inherited and acquired forms.
@en
P2093
P356
P1433
P1476
Coagulation factor XIII defici ...... inherited and acquired forms.
@en
P2093
J Oldenburg
V Ivaskevicius
P304
P356
10.5482/HAMO-13-08-0046
P577
2014-02-07T00:00:00Z